CUE BIOPHARMA INC. -
1.7600
07-十一月-24 10:25:57
15 分钟延时
股票
+0.1100
+6.67%
今日范围
1.5900 - 1.8000
ISIN
N/A
来源
NASDAQ
-
04 10月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
Cue Biopharma Announces Pricing of $12.0 Million Public Offering
26 9月 2024 23:26:30 条件 Nasdaq GlobeNewswire
-
Cue Biopharma Announces Proposed Public Offering
26 9月 2024 23:10:15 条件 Nasdaq GlobeNewswire
-
Cue Biopharma Announces Proposed Public Offering
26 9月 2024 16:27:02 条件 Nasdaq GlobeNewswire
-
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer
09 9月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
03 9月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
19 8月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast
13 8月 2024 08:00:01 条件 Nasdaq GlobeNewswire
-
25 7月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
04 6月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024
03 6月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
09 5月 2024 16:05:01 条件 Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
08 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference
07 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24 4月 2024 10:01:00 条件 Nasdaq GlobeNewswire
-
08 4月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast
02 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
29 2月 2024 10:00:00 条件 Nasdaq GlobeNewswire
-
06 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit
22 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >